Market Overview

UPDATE: Wedbush Raises PT to $38 on Molina Healthcare on Medicaid Expansion

Share:
Related MOH
Looking Past M&A: The Best Managed Care Stock Plays For The Long Haul
Mid-Day Market Update: Aratana Therapeutics Jumps Following Positive Pivotal Results for AT-002; MBIA Shares Slip
Molina Healthcare's (MOH) CEO Dr. Mario Molina on Q2 2015 Results - Earnings Call Transcript (Seeking Alpha)

Wedbush maintained Molina Healthcare (NYSE: MOH) with an Outperform rating and raised the price target from $33.00 to $38.00.

Wedbush analyst Sarah James wrote, "Raising price target to $38 from $33 and updating estimates to reflect Medicaid expansion and convert offering. While new contract implementations can create short-term margin pressure, we believe the path to growth is clear for MOH and 2015 earnings could be in the $2.75-3.50 range. If we use 2015 as a new run rate and discount the multiple back, we see MOH as undervalued."

Molina Healthcare closed at $33.32 on Wednesday.

Latest Ratings for MOH

DateFirmActionFromTo
Jul 2015JefferiesMaintainsBuy
Jun 2015UBSInitiates Coverage onBuy
Jun 2015Deutsche BankMaintainsHold

View More Analyst Ratings for MOH
View the Latest Analyst Ratings

Posted-In: WedbushAnalyst Color Price Target Analyst Ratings

 

Related Articles (MOH)

Get Benzinga's Newsletters